26 results
Thumbnail

D2.541 - Healthy and unhealthy plant-based dietary patterns and asthma: a systematic review using validated dietary indices

Thumbnail

D2.542 - Prevalance and risk factors of atopic dermatitis among preschool children Gaziantep, a province in South-Eastern Turkey

Thumbnail

D2.540 - Nationwide Analysis of Domestic Mites in Germany

Thumbnail

D2.543 - Clinical and Epidemiological Characteristics of Workers with Inflammatory Bowel Disease: A Cross-Sectional Study

Thumbnail

D2.544 - Validation of the Turkish Version of the Mastocytosis Control Test

Thumbnail

D3.288 - Evaluating the role of dust mite sensitization in the development of edible insect allergies

Thumbnail

D3.289 - Tolerance Assessment in Children with IgE-Mediated Cow's Milk Allergy Using Different Cutoff Values of Cow’s Milk Specific IgE

Thumbnail

D3.284 - Milk Aversion After Successful Desensitization in a Milk-Allergic Child

Thumbnail

D3.283 - Oat-Induced Anaphylaxis: Allergenic Characterization in a Clinical Case

Thumbnail

D3.286 - Infant feeding patterns, perinatal history and the development of food allergy in early childhood

Thumbnail

D3.287 - Tick Bite–Induced Alpha-Gal Syndrome: A Report of Two Cases and Literature Review Focusing on Clinical Characteristics of Asian Patients

Thumbnail

D3.290 - Generalized Urticaria Induced from Prick-by-Prick Test in Food Allergy Diagnosis

Thumbnail

D3.291 - Molecular Identification of Heat-Stable β-Parvalbumin in megrim (Lepidorhombus boscii) as the Likely Allergen in a Child With Selective Fish Reactivity

Thumbnail

D3.292 - Safety profile of the yellow fever vaccine in egg-allergic children

Thumbnail

D3.293 - Selective Quail Egg Allergy Without Cross-Reactivity to Hen’s Egg: Molecular Characterization of a Pediatric Case

Thumbnail

D3.418 - A Phase 1b Study of Lesigercept, a Long-acting High-affinity IgETrap-Fc Fusion Protein: Safety, Tolerability, PK, and PD in Atopic Healthy and Allergic Subjects

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.421 - Real-world Effectiveness and Safety of Lanadelumab Treatment in Patients With Hereditary Angioedema: The 12-Month Interim Analysis of a Polish, Prospective, Multicenter, Observational Study (CHOPIN)

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes